nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—esophageal cancer	0.798	1	CbGaD
Mannitol—ABCB1—Cisplatin—esophageal cancer	0.0167	0.607	CbGbCtD
Mannitol—ABCB1—Methotrexate—esophageal cancer	0.0108	0.394	CbGbCtD
Mannitol—Venous thrombosis—Carboplatin—esophageal cancer	0.00884	0.0506	CcSEcCtD
Mannitol—Odynophagia—Capecitabine—esophageal cancer	0.00823	0.0471	CcSEcCtD
Mannitol—Fluid overload—Carboplatin—esophageal cancer	0.00767	0.044	CcSEcCtD
Mannitol—Extravasation—Carboplatin—esophageal cancer	0.00547	0.0313	CcSEcCtD
Mannitol—Bronchopneumonia—Capecitabine—esophageal cancer	0.00472	0.0271	CcSEcCtD
Mannitol—Lung infection—Methotrexate—esophageal cancer	0.00468	0.0268	CcSEcCtD
Mannitol—Diuresis—Cisplatin—esophageal cancer	0.00451	0.0259	CcSEcCtD
Mannitol—Phlebitis—Carboplatin—esophageal cancer	0.00402	0.023	CcSEcCtD
Mannitol—Skin necrosis—Cisplatin—esophageal cancer	0.00401	0.0229	CcSEcCtD
Mannitol—Joint stiffness—Capecitabine—esophageal cancer	0.00342	0.0196	CcSEcCtD
Mannitol—Obstructive airways disorder—Methotrexate—esophageal cancer	0.00338	0.0194	CcSEcCtD
Mannitol—Venous thrombosis—Cisplatin—esophageal cancer	0.00259	0.0149	CcSEcCtD
Mannitol—Fluid overload—Cisplatin—esophageal cancer	0.00225	0.0129	CcSEcCtD
Mannitol—Prurigo—Capecitabine—esophageal cancer	0.00223	0.0128	CcSEcCtD
Mannitol—Skin necrosis—Methotrexate—esophageal cancer	0.0022	0.0126	CcSEcCtD
Mannitol—Venous thrombosis—Capecitabine—esophageal cancer	0.00191	0.0109	CcSEcCtD
Mannitol—Rhinorrhoea—Cisplatin—esophageal cancer	0.00173	0.0099	CcSEcCtD
Mannitol—Infection—Carboplatin—esophageal cancer	0.00169	0.00969	CcSEcCtD
Mannitol—Oral candidiasis—Capecitabine—esophageal cancer	0.00162	0.0093	CcSEcCtD
Mannitol—Extravasation—Cisplatin—esophageal cancer	0.0016	0.00919	CcSEcCtD
Mannitol—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00153	0.00875	CcSEcCtD
Mannitol—Laryngeal pain—Capecitabine—esophageal cancer	0.00151	0.00867	CcSEcCtD
Mannitol—Pain—Carboplatin—esophageal cancer	0.00146	0.00834	CcSEcCtD
Mannitol—Throat sore—Capecitabine—esophageal cancer	0.00143	0.0082	CcSEcCtD
Mannitol—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00142	0.00813	CcSEcCtD
Mannitol—Haemoptysis—Capecitabine—esophageal cancer	0.00139	0.00798	CcSEcCtD
Mannitol—Wheezing—Cisplatin—esophageal cancer	0.00136	0.00779	CcSEcCtD
Mannitol—Body temperature increased—Carboplatin—esophageal cancer	0.00135	0.00771	CcSEcCtD
Mannitol—Skin exfoliation—Cisplatin—esophageal cancer	0.00134	0.00765	CcSEcCtD
Mannitol—Rhinorrhoea—Capecitabine—esophageal cancer	0.00127	0.00729	CcSEcCtD
Mannitol—Dysphonia—Capecitabine—esophageal cancer	0.00125	0.00718	CcSEcCtD
Mannitol—Hypoxia—Methotrexate—esophageal cancer	0.00121	0.00693	CcSEcCtD
Mannitol—Phlebitis—Cisplatin—esophageal cancer	0.00118	0.00675	CcSEcCtD
Mannitol—Chest discomfort—Capecitabine—esophageal cancer	0.00117	0.00668	CcSEcCtD
Mannitol—Polyuria—Cisplatin—esophageal cancer	0.00116	0.00663	CcSEcCtD
Mannitol—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00114	0.00654	CcSEcCtD
Mannitol—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00113	0.0065	CcSEcCtD
Mannitol—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00112	0.00642	CcSEcCtD
Mannitol—Lung disorder—Methotrexate—esophageal cancer	0.00108	0.00622	CcSEcCtD
Mannitol—Hyponatraemia—Cisplatin—esophageal cancer	0.00102	0.00584	CcSEcCtD
Mannitol—Influenza like illness—Capecitabine—esophageal cancer	0.001	0.00574	CcSEcCtD
Mannitol—Urinary incontinence—Capecitabine—esophageal cancer	0.000996	0.00571	CcSEcCtD
Mannitol—Skin exfoliation—Capecitabine—esophageal cancer	0.000985	0.00564	CcSEcCtD
Mannitol—Candida infection—Capecitabine—esophageal cancer	0.000985	0.00564	CcSEcCtD
Mannitol—Dehydration—Cisplatin—esophageal cancer	0.000945	0.00541	CcSEcCtD
Mannitol—Nasopharyngitis—Cisplatin—esophageal cancer	0.000908	0.0052	CcSEcCtD
Mannitol—Extravasation—Methotrexate—esophageal cancer	0.00088	0.00504	CcSEcCtD
Mannitol—Ear pain—Capecitabine—esophageal cancer	0.000878	0.00503	CcSEcCtD
Mannitol—Phlebitis—Capecitabine—esophageal cancer	0.000869	0.00498	CcSEcCtD
Mannitol—Thrombophlebitis—Capecitabine—esophageal cancer	0.000865	0.00496	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000861	0.00493	CcSEcCtD
Mannitol—Diabetes mellitus—Capecitabine—esophageal cancer	0.000861	0.00493	CcSEcCtD
Mannitol—Polyuria—Capecitabine—esophageal cancer	0.000853	0.00489	CcSEcCtD
Mannitol—Thirst—Capecitabine—esophageal cancer	0.000787	0.00451	CcSEcCtD
Mannitol—Renal failure—Cisplatin—esophageal cancer	0.00077	0.00441	CcSEcCtD
Mannitol—Cardiac failure—Capecitabine—esophageal cancer	0.000767	0.0044	CcSEcCtD
Mannitol—Stomatitis—Cisplatin—esophageal cancer	0.000763	0.00437	CcSEcCtD
Mannitol—Hyponatraemia—Capecitabine—esophageal cancer	0.000752	0.00431	CcSEcCtD
Mannitol—Pain in extremity—Capecitabine—esophageal cancer	0.000749	0.00429	CcSEcCtD
Mannitol—Skin exfoliation—Methotrexate—esophageal cancer	0.000733	0.0042	CcSEcCtD
Mannitol—Urinary retention—Capecitabine—esophageal cancer	0.000712	0.00408	CcSEcCtD
Mannitol—Dehydration—Capecitabine—esophageal cancer	0.000696	0.00399	CcSEcCtD
Mannitol—Urinary tract disorder—Cisplatin—esophageal cancer	0.000694	0.00398	CcSEcCtD
Mannitol—Connective tissue disorder—Cisplatin—esophageal cancer	0.000691	0.00396	CcSEcCtD
Mannitol—Urethral disorder—Cisplatin—esophageal cancer	0.000689	0.00395	CcSEcCtD
Mannitol—Abdominal pain upper—Capecitabine—esophageal cancer	0.000684	0.00392	CcSEcCtD
Mannitol—Pulmonary oedema—Methotrexate—esophageal cancer	0.000684	0.00392	CcSEcCtD
Mannitol—Nasopharyngitis—Capecitabine—esophageal cancer	0.00067	0.00384	CcSEcCtD
Mannitol—Thrombophlebitis—Methotrexate—esophageal cancer	0.000644	0.00369	CcSEcCtD
Mannitol—Diabetes mellitus—Methotrexate—esophageal cancer	0.000641	0.00367	CcSEcCtD
Mannitol—Bronchospasm—Capecitabine—esophageal cancer	0.000637	0.00365	CcSEcCtD
Mannitol—Polyuria—Methotrexate—esophageal cancer	0.000635	0.00364	CcSEcCtD
Mannitol—Mediastinal disorder—Cisplatin—esophageal cancer	0.000633	0.00363	CcSEcCtD
Mannitol—Angina pectoris—Capecitabine—esophageal cancer	0.00063	0.00361	CcSEcCtD
Mannitol—Bronchitis—Capecitabine—esophageal cancer	0.000622	0.00357	CcSEcCtD
Mannitol—Malnutrition—Cisplatin—esophageal cancer	0.000612	0.0035	CcSEcCtD
Mannitol—Flatulence—Cisplatin—esophageal cancer	0.000603	0.00345	CcSEcCtD
Mannitol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000602	0.00345	CcSEcCtD
Mannitol—Infestation NOS—Capecitabine—esophageal cancer	0.000577	0.00331	CcSEcCtD
Mannitol—Infestation—Capecitabine—esophageal cancer	0.000577	0.00331	CcSEcCtD
Mannitol—Vision blurred—Cisplatin—esophageal cancer	0.000577	0.0033	CcSEcCtD
Mannitol—Ill-defined disorder—Cisplatin—esophageal cancer	0.000568	0.00325	CcSEcCtD
Mannitol—Renal failure—Capecitabine—esophageal cancer	0.000567	0.00325	CcSEcCtD
Mannitol—Stomatitis—Capecitabine—esophageal cancer	0.000562	0.00322	CcSEcCtD
Mannitol—Malaise—Cisplatin—esophageal cancer	0.000552	0.00316	CcSEcCtD
Mannitol—Convulsion—Cisplatin—esophageal cancer	0.00053	0.00304	CcSEcCtD
Mannitol—Rhinitis—Capecitabine—esophageal cancer	0.000519	0.00298	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000517	0.00296	CcSEcCtD
Mannitol—Discomfort—Cisplatin—esophageal cancer	0.000515	0.00295	CcSEcCtD
Mannitol—Pharyngitis—Capecitabine—esophageal cancer	0.000514	0.00295	CcSEcCtD
Mannitol—Urinary tract disorder—Capecitabine—esophageal cancer	0.000512	0.00293	CcSEcCtD
Mannitol—Connective tissue disorder—Capecitabine—esophageal cancer	0.000509	0.00292	CcSEcCtD
Mannitol—Urethral disorder—Capecitabine—esophageal cancer	0.000508	0.00291	CcSEcCtD
Mannitol—Oedema—Cisplatin—esophageal cancer	0.000499	0.00286	CcSEcCtD
Mannitol—Infection—Cisplatin—esophageal cancer	0.000496	0.00284	CcSEcCtD
Mannitol—Nervous system disorder—Cisplatin—esophageal cancer	0.00049	0.0028	CcSEcCtD
Mannitol—Tachycardia—Cisplatin—esophageal cancer	0.000487	0.00279	CcSEcCtD
Mannitol—Skin disorder—Cisplatin—esophageal cancer	0.000485	0.00278	CcSEcCtD
Mannitol—Mediastinal disorder—Capecitabine—esophageal cancer	0.000467	0.00267	CcSEcCtD
Mannitol—Hypotension—Cisplatin—esophageal cancer	0.000467	0.00267	CcSEcCtD
Mannitol—Chills—Capecitabine—esophageal cancer	0.000465	0.00266	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000455	0.00261	CcSEcCtD
Mannitol—Mental disorder—Capecitabine—esophageal cancer	0.000454	0.0026	CcSEcCtD
Mannitol—Malnutrition—Capecitabine—esophageal cancer	0.000451	0.00258	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000448	0.00257	CcSEcCtD
Mannitol—Dyspnoea—Cisplatin—esophageal cancer	0.000445	0.00255	CcSEcCtD
Mannitol—Flatulence—Capecitabine—esophageal cancer	0.000444	0.00255	CcSEcCtD
Mannitol—Back pain—Capecitabine—esophageal cancer	0.000436	0.0025	CcSEcCtD
Mannitol—Decreased appetite—Cisplatin—esophageal cancer	0.000434	0.00249	CcSEcCtD
Mannitol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000431	0.00247	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—esophageal cancer	0.00043	0.00246	CcSEcCtD
Mannitol—Infestation—Methotrexate—esophageal cancer	0.00043	0.00246	CcSEcCtD
Mannitol—Pain—Cisplatin—esophageal cancer	0.000427	0.00245	CcSEcCtD
Mannitol—Vision blurred—Capecitabine—esophageal cancer	0.000425	0.00243	CcSEcCtD
Mannitol—Renal failure—Methotrexate—esophageal cancer	0.000422	0.00242	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—esophageal cancer	0.000419	0.0024	CcSEcCtD
Mannitol—Ill-defined disorder—Capecitabine—esophageal cancer	0.000418	0.0024	CcSEcCtD
Mannitol—Feeling abnormal—Cisplatin—esophageal cancer	0.000411	0.00236	CcSEcCtD
Mannitol—Malaise—Capecitabine—esophageal cancer	0.000407	0.00233	CcSEcCtD
Mannitol—Vertigo—Capecitabine—esophageal cancer	0.000405	0.00232	CcSEcCtD
Mannitol—Body temperature increased—Cisplatin—esophageal cancer	0.000395	0.00226	CcSEcCtD
Mannitol—Cough—Capecitabine—esophageal cancer	0.000394	0.00225	CcSEcCtD
Mannitol—Hypertension—Capecitabine—esophageal cancer	0.000389	0.00223	CcSEcCtD
Mannitol—Arthralgia—Capecitabine—esophageal cancer	0.000384	0.0022	CcSEcCtD
Mannitol—Chest pain—Capecitabine—esophageal cancer	0.000384	0.0022	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—esophageal cancer	0.000383	0.00219	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000381	0.00218	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—esophageal cancer	0.000381	0.00218	CcSEcCtD
Mannitol—Discomfort—Capecitabine—esophageal cancer	0.000379	0.00217	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—esophageal cancer	0.000378	0.00217	CcSEcCtD
Mannitol—Oedema—Capecitabine—esophageal cancer	0.000368	0.00211	CcSEcCtD
Mannitol—Hypersensitivity—Cisplatin—esophageal cancer	0.000368	0.00211	CcSEcCtD
Mannitol—Infection—Capecitabine—esophageal cancer	0.000366	0.00209	CcSEcCtD
Mannitol—Nervous system disorder—Capecitabine—esophageal cancer	0.000361	0.00207	CcSEcCtD
Mannitol—Tachycardia—Capecitabine—esophageal cancer	0.000359	0.00206	CcSEcCtD
Mannitol—Asthenia—Cisplatin—esophageal cancer	0.000358	0.00205	CcSEcCtD
Mannitol—Skin disorder—Capecitabine—esophageal cancer	0.000357	0.00205	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—esophageal cancer	0.000348	0.00199	CcSEcCtD
Mannitol—Chills—Methotrexate—esophageal cancer	0.000346	0.00198	CcSEcCtD
Mannitol—Hypotension—Capecitabine—esophageal cancer	0.000344	0.00197	CcSEcCtD
Mannitol—Diarrhoea—Cisplatin—esophageal cancer	0.000342	0.00196	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—esophageal cancer	0.000338	0.00194	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—esophageal cancer	0.000336	0.00192	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000335	0.00192	CcSEcCtD
Mannitol—Dyspnoea—Capecitabine—esophageal cancer	0.000328	0.00188	CcSEcCtD
Mannitol—Back pain—Methotrexate—esophageal cancer	0.000325	0.00186	CcSEcCtD
Mannitol—Decreased appetite—Capecitabine—esophageal cancer	0.00032	0.00183	CcSEcCtD
Mannitol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000318	0.00182	CcSEcCtD
Mannitol—Vomiting—Cisplatin—esophageal cancer	0.000317	0.00182	CcSEcCtD
Mannitol—Fatigue—Capecitabine—esophageal cancer	0.000317	0.00182	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—esophageal cancer	0.000316	0.00181	CcSEcCtD
Mannitol—Rash—Cisplatin—esophageal cancer	0.000315	0.0018	CcSEcCtD
Mannitol—Pain—Capecitabine—esophageal cancer	0.000315	0.0018	CcSEcCtD
Mannitol—Dermatitis—Cisplatin—esophageal cancer	0.000315	0.0018	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—esophageal cancer	0.000311	0.00178	CcSEcCtD
Mannitol—Feeling abnormal—Capecitabine—esophageal cancer	0.000303	0.00174	CcSEcCtD
Mannitol—Malaise—Methotrexate—esophageal cancer	0.000303	0.00173	CcSEcCtD
Mannitol—Vertigo—Methotrexate—esophageal cancer	0.000302	0.00173	CcSEcCtD
Mannitol—Nausea—Cisplatin—esophageal cancer	0.000297	0.0017	CcSEcCtD
Mannitol—Cough—Methotrexate—esophageal cancer	0.000293	0.00168	CcSEcCtD
Mannitol—Urticaria—Capecitabine—esophageal cancer	0.000292	0.00167	CcSEcCtD
Mannitol—Body temperature increased—Capecitabine—esophageal cancer	0.000291	0.00167	CcSEcCtD
Mannitol—Convulsion—Methotrexate—esophageal cancer	0.000291	0.00167	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—esophageal cancer	0.000286	0.00164	CcSEcCtD
Mannitol—Chest pain—Methotrexate—esophageal cancer	0.000286	0.00164	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000284	0.00163	CcSEcCtD
Mannitol—Discomfort—Methotrexate—esophageal cancer	0.000282	0.00162	CcSEcCtD
Mannitol—Infection—Methotrexate—esophageal cancer	0.000272	0.00156	CcSEcCtD
Mannitol—Hypersensitivity—Capecitabine—esophageal cancer	0.000271	0.00155	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—esophageal cancer	0.000269	0.00154	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—esophageal cancer	0.000266	0.00152	CcSEcCtD
Mannitol—Asthenia—Capecitabine—esophageal cancer	0.000264	0.00151	CcSEcCtD
Mannitol—Pruritus—Capecitabine—esophageal cancer	0.00026	0.00149	CcSEcCtD
Mannitol—Hypotension—Methotrexate—esophageal cancer	0.000256	0.00147	CcSEcCtD
Mannitol—Diarrhoea—Capecitabine—esophageal cancer	0.000252	0.00144	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00025	0.00143	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—esophageal cancer	0.000244	0.0014	CcSEcCtD
Mannitol—Dizziness—Capecitabine—esophageal cancer	0.000243	0.00139	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—esophageal cancer	0.000238	0.00136	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000237	0.00136	CcSEcCtD
Mannitol—Fatigue—Methotrexate—esophageal cancer	0.000236	0.00135	CcSEcCtD
Mannitol—Pain—Methotrexate—esophageal cancer	0.000234	0.00134	CcSEcCtD
Mannitol—Vomiting—Capecitabine—esophageal cancer	0.000234	0.00134	CcSEcCtD
Mannitol—Rash—Capecitabine—esophageal cancer	0.000232	0.00133	CcSEcCtD
Mannitol—Dermatitis—Capecitabine—esophageal cancer	0.000232	0.00133	CcSEcCtD
Mannitol—Headache—Capecitabine—esophageal cancer	0.000231	0.00132	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—esophageal cancer	0.000226	0.00129	CcSEcCtD
Mannitol—Nausea—Capecitabine—esophageal cancer	0.000219	0.00125	CcSEcCtD
Mannitol—Urticaria—Methotrexate—esophageal cancer	0.000218	0.00125	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—esophageal cancer	0.000217	0.00124	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—esophageal cancer	0.000202	0.00116	CcSEcCtD
Mannitol—Asthenia—Methotrexate—esophageal cancer	0.000197	0.00113	CcSEcCtD
Mannitol—Pruritus—Methotrexate—esophageal cancer	0.000194	0.00111	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—esophageal cancer	0.000187	0.00107	CcSEcCtD
Mannitol—Dizziness—Methotrexate—esophageal cancer	0.000181	0.00104	CcSEcCtD
Mannitol—Vomiting—Methotrexate—esophageal cancer	0.000174	0.000998	CcSEcCtD
Mannitol—Rash—Methotrexate—esophageal cancer	0.000173	0.00099	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—esophageal cancer	0.000173	0.000989	CcSEcCtD
Mannitol—Headache—Methotrexate—esophageal cancer	0.000172	0.000983	CcSEcCtD
Mannitol—Nausea—Methotrexate—esophageal cancer	0.000163	0.000932	CcSEcCtD
